Merck & Co., Inc.

MRK Health Care · Pharmaceuticals & Biotechnology

Latest period 2026-06-30 · 39 filings on record

Quarterly TTM Annual

8Q 3Y 5Y 10Y MAX

TTM 24-09 → TTM 26-06 8 TTM POINTS

SHOWING Trailing twelve months — each point sums the four quarters ending there.

Ranked against Health Care · 51 peers

Each grade is a single reported quarter's assessment, never an average — a card shows the grade at the newest quarter in view, so it follows the period and range controls above. Latest scored quarter: 2026-06-30.

Growth 17th pct

▼−13 over range · as of 2026-06-30

Revenue +5.1% YoY, earnings -130.2% YoY · sector avg 66

Quality 29th pct

▼−30 over range · as of 2026-06-30

-8.0% net margin, 8% return on equity, 24% free-cash-flow margin, profitable in 6 of last 8 quarters · sector avg 45

Safety 38th pct

▼−3 over range · as of 2026-06-30

1.3x current ratio · sector avg 65

OVERVIEWvs prior TTM Δ

Trailing twelve months · ending 2026-06-30 · green = improving · click a row to chart it

Revenue $66.6B +1.2% Gross margin 73.0% −0.9pp Operating margin — — Net margin 4.8% −8.8pp Net income $3.2B −64.5%

Debt / equity 1.28 +20.1%

EPS (diluted) — — EBITDA — —

Filings

TTM 24-09 → TTM 26-06 · following the period bar 12 match

ALL 10-K 10-Q Q1 Q2 Q3 FY SORT NEWEST ↓

Filings by fiscal year and period
Year	Q1	Q2	Q3	FY
2026	10-Q Q1 2026	10-Q Q2 2026	no filing	no filing
2025	10-Q Q1 2025	10-Q Q2 2025	10-Q Q3 2025	10-K FY 2025
2024	10-Q Q1 2024	10-Q Q2 2024	10-Q Q3 2024	10-K FY 2024
2023	no filing	no filing	no filing	10-K FY 2023

10-Q Q2 2026 2026-08-07 Pro → 10-Q Q1 2026 2026-05-04 Pro → 10-K FY 2025 2026-02-24 Pro → 10-Q Q3 2025 2025-11-05 Pro → 10-Q Q2 2025 2025-08-05 Pro → 10-Q Q1 2025 2025-05-02 Pro →

All 12 filings

10-K FY 2024 2025-02-25 Pro → 10-Q Q3 2024 2024-11-06 Pro → 10-Q Q2 2024 2024-08-05 Pro → 10-Q Q1 2024 2024-05-03 Pro → 10-K/A FY 2024-04-11 Pro → 10-K FY 2023 2024-02-26 Pro →

Filing-level fact detail is a Pro feature. The grades and figures above are free. See Pro plans

Trends

Trailing twelve months, rolling one quarter at a time

Revenue

Latest$66.6B vs prior TTM+1.2% Periods8

Revenue by period
Period	Period end	Revenue
TTM 24-09	2024-09-30	$63.2B
TTM 24-12	2024-12-31	$64.2B
TTM 25-03	2025-03-31	$63.9B
TTM 25-06	2025-06-30	$63.6B
TTM 25-09	2025-09-30	$64.2B
TTM 25-12	2025-12-31	$65.0B
TTM 26-03	2026-03-31	$65.8B
TTM 26-06	2026-06-30	$66.6B

Net income

Latest$3.2B vs prior TTM−64.5% Periods8

Net income by period
Period	Period end	Net income
TTM 24-09	2024-09-30	$12.1B
TTM 24-12	2024-12-31	$17.1B
TTM 25-03	2025-03-31	$17.4B
TTM 25-06	2025-06-30	$16.4B
TTM 25-09	2025-09-30	$19.0B
TTM 25-12	2025-12-31	$18.3B
TTM 26-03	2026-03-31	$8.9B
TTM 26-06	2026-06-30	$3.2B

ZOOM

TTM 19-12 TTM 26-06

Grade history

Point-in-time: each period shows the grade of the quarter it ends at — grades are never summed or averaged across a window.

Growth 17 Quality 29 Safety 38

Hover to read every grade at a period · shared with the trends chart · axis fixed 0–100

Grade history by period
Period	Period end	Growth	Quality	Safety
TTM 24-09	2024-09-30	30	60	41
TTM 24-12	2024-12-31	73	64	46
TTM 25-03	2025-03-31	36	69	43
TTM 25-06	2025-06-30	12	69	50
TTM 25-09	2025-09-30	57	64	55
TTM 25-12	2025-12-31	21	71	48
TTM 26-03	2026-03-31	15	38	34
TTM 26-06	2026-06-30	17	29	38